CD8A and cancer: The authors indeed demonstrated that their system stimulated anti‐tumoral CD8+ T cell response.[114] In a recent study, a dual drug‐loaded NP formulation was shown to accumulate selectively within TAMs and to improve anti‐tumor efficacy in murine cancer models.[115]